Journey Medical (DERM) Gross Margin (2020 - 2025)
Historic Gross Margin for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to 67.36%.
- Journey Medical's Gross Margin fell 20800.0% to 67.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 66.05%, marking a year-over-year decrease of 20100.0%. This contributed to the annual value of 62.81% for FY2024, which is 82800.0% down from last year.
- Per Journey Medical's latest filing, its Gross Margin stood at 67.36% for Q3 2025, which was down 20800.0% from 67.09% recorded in Q2 2025.
- Journey Medical's 5-year Gross Margin high stood at 85.27% for Q4 2023, and its period low was 43.05% during Q3 2021.
- Over the past 5 years, Journey Medical's median Gross Margin value was 61.45% (recorded in 2024), while the average stood at 60.54%.
- In the last 5 years, Journey Medical's Gross Margin crashed by -231800bps in 2021 and then soared by 336100bps in 2023.
- Quarter analysis of 5 years shows Journey Medical's Gross Margin stood at 45.62% in 2021, then rose by 13bps to 51.66% in 2022, then soared by 65bps to 85.27% in 2023, then decreased by -23bps to 65.64% in 2024, then rose by 3bps to 67.36% in 2025.
- Its last three reported values are 67.36% in Q3 2025, 67.09% for Q2 2025, and 63.54% during Q1 2025.